Brand:-
Model:-
MOQ:-0 -
Clorsulon Anti Schistosomiasis Drugs / Antiparasitic CAS No. 60200-06-8
| Name | Clorsulon |
| Synonyms | 4-Amino-6-(trichlorovinyl)-1,3-benzenedisulfonamide |
| Molecular Formula | C8H8Cl3N3O4S2 |
| Molecular Weight | 380.65 |
| CAS Registry Number | 60200-06-8 |
| EINECS | 262-100-2 |
Application:
Clorsulon is approved for use in the treatment of immature and adult forms of Fasciola hepatica (Liver fluke) in cattle. It is not effective against immature flukes less than 8 weeks old. It also has activity against Fasciola gigantica. Although not approved, the drug has been used in practice in various other species (e.g., sheep, llamas). It has activity against F. magna in sheep, but is not completely effective in eradicating the organism after a single dose, thereby severely limiting its clinical usefulness against this parasite. Clorsulon is also not effective against the rumen fluke (Paramphistomum).
COMPANY INTRODUCTION:
Our company, as one of the most experienced exporter in China,specializes in API
and medicine intermediates. We export large quantity to USA,Europe and many other
countries all of the world, deal to high quality and reasonable price.
Patent Disclaimer:
1. Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
2. Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
3. R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.
